Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis

Vaccine
Vanitha MariappanJamuna Vadivelu

Abstract

Burkholderia cepacia is an opportunistic human pathogen associated with lung infections. Secretory proteins of B. cepacia are known to be involved in virulence and may mediate important host-pathogen interactions. In the present study, secretory proteins isolated from B. cepacia culture supernatant were separated using two-dimensional gel electrophoresis, followed by Western blot analysis to identify the immunogenic proteins. Mice antibodies raised to B. cepacia inactivated whole bacteria, outer membrane protein and culture filtrate antigen detected 74, 104 and 32 immunogenic proteins, respectively. Eighteen of these immunogenic proteins which reacted with all three antibodies were identified and might be potential molecules as a diagnostic marker or a putative candidate vaccine against B. cepacia infections.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Dec 1, 1996·Journal of Medical Microbiology·J R GovanP Vandamme
Dec 3, 1999·Microbes and Infection·D H Schmiel, V L Miller
May 12, 2000·European Journal of Biochemistry·M P MolloyA A Gooley
Feb 15, 2001·Diagnostic Microbiology and Infectious Disease·V ChenthamarakshanS D Puthucheary
May 23, 2001·Microbes and Infection·C D MohrC A Herfst
Jun 18, 2002·Infection and Immunity·Dirk BumannPeter R Jungblut
Aug 9, 2003·Microbiology·C R CorbettP A Sokol
Aug 21, 2003·Electrophoresis·Xiang LiaoPeitang Huang
Oct 2, 2004·Current Biology : CB·Brian K CoombesB Brett Finlay
Sep 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·M J J B SibbaldJ M van Dijl
Oct 13, 2006·Molecular and Cellular Probes·Patompon WongtrakoongateSumalee Tungpradabkul
Sep 18, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T MullenM Callaghan
Feb 12, 2008·Nature Reviews. Microbiology·Yong-Mei Zhang, Charles O Rock

❮ Previous
Next ❯

Citations

Sep 3, 2010·Journal of Clinical Microbiology·Tiffany MottGregory C Whitlock
Jan 12, 2013·Current Protein & Peptide Science·Ruth Dennehy, Siobhan McClean
Jun 21, 2011·Omics : a Journal of Integrative Biology·Fabio BagnoliRino Rappuoli
Jul 20, 2012·Expert Review of Proteomics·Kristy J BrownYetrib Hathout
Feb 7, 2012·Diagnostic Microbiology and Infectious Disease·Chi-Won ChoiSeung Il Kim
Nov 25, 2014·Proteomics. Clinical Applications·Karthik Shantharam KamathMark P Molloy
Jul 29, 2016·World Journal of Microbiology & Biotechnology·Pratistha DwivediRajesh Singh Tomar
Dec 17, 2020·Cells·Guanbo WangMiguel A Valvano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

© 2022 Meta ULC. All rights reserved